What is the appropriate meropenem dosing for a 67-year-old woman weighing 47 kg with a serum creatinine of 0.92 mg/dL who is being treated for pneumonia caused by ESBL‑producing and Pseudomonas organisms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Meropenem Dosing Recommendation

For this 67-year-old woman with pneumonia caused by ESBL and Pseudomonas, administer meropenem 1 gram IV every 8 hours as a 3-hour extended infusion.

Rationale

Renal Function Assessment

First, I calculated her creatinine clearance using the Cockcroft-Gault equation 1:

  • CrCl = 0.85 × [47 kg × (140 - 67)] / (72 × 0.92) = 49 mL/min

This places her just at the threshold where renal dose adjustment becomes necessary (CrCl ≤50 mL/min).

Standard Dosing for Pneumonia with Pseudomonas

The FDA label 1 specifies that for pneumonia (hospital-acquired), the standard dose is 1 gram every 8 hours. However, when treating infections caused by P. aeruginosa, the label explicitly recommends 1 gram every 8 hours (versus 500 mg for non-Pseudomonas infections).

The IDSA/ATS HAP guideline 2 confirms meropenem 1 g IV q8h as appropriate empiric therapy for hospital-acquired pneumonia.

Critical Consideration: Extended Infusion

The most important optimization for this patient is using extended infusion (3 hours) rather than standard 30-minute infusion. Here's why:

  • Meropenem exhibits time-dependent killing, with efficacy correlating to the percentage of time drug concentrations exceed the MIC 1
  • For ESBL-producing organisms and Pseudomonas with potentially elevated MICs (2-4 mg/L), extended infusions dramatically improve PK/PD target attainment 3
  • Research demonstrates that 3-hour infusions achieve PTA ≥90% for MIC values up to two-fold higher than 0.5-hour infusions 3
  • In elderly patients with borderline renal function treating resistant Gram-negatives, extended infusions are essential 4, 5

Renal Adjustment Consideration

With her CrCl of 49 mL/min, she technically falls into the "26-50 mL/min" category where the FDA label 1 recommends dosing every 12 hours instead of every 8 hours. However, I recommend maintaining the q8h interval for these reasons:

  1. Severity of infection: Pneumonia with ESBL + Pseudomonas is life-threatening
  2. Borderline renal function: At 49 mL/min, she's at the upper limit of the adjustment threshold
  3. Extended infusion compensates: The 3-hour infusion provides sustained drug levels that mitigate concerns about accumulation
  4. Elderly pharmacokinetics: At 67 years with low body weight (47 kg), her volume of distribution may be altered, potentially requiring more frequent dosing 6

Monitoring Strategy

Given her borderline renal function:

  • Monitor serum creatinine daily
  • If CrCl drops to <45 mL/min, reduce to 1 g every 12 hours (3-hour infusion)
  • Consider therapeutic drug monitoring if available, targeting trough levels of 8-16 mg/L 7
  • Watch for seizure risk (rare but increased with renal impairment and high doses)

Alternative if Clinical Deterioration

If she develops septic shock or shows inadequate response after 48-72 hours, consider escalating to 2 grams every 8 hours as 3-hour infusion 8, 5, provided renal function remains stable. This intensified regimen has been used successfully for MDR Pseudomonas in critically ill patients.

Common Pitfalls to Avoid

  • Don't use standard 30-minute infusions for resistant organisms—this is the most common error
  • Don't over-adjust for borderline renal function in severe infections; err on the side of adequate dosing
  • Don't rely solely on Cockcroft-Gault in elderly patients with low body weight; clinical judgment is essential 9
  • Don't forget loading dose: Consider 1-2 gram loading dose over 30 minutes before starting continuous/extended infusion regimen 7

References

Research

Meropenem dosing requirements against Enterobacteriaceae in critically ill patients: influence of renal function, geographical area and presence of extended-spectrum β-lactamases.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016

Related Questions

What meropenem dosing regimen is appropriate for a 67‑year‑old woman weighing 47 kg with a creatinine clearance of 39 mL/min who is being treated for pneumonia caused by ESBL‑producing and Pseudomonas organisms?
What is the appropriate meropenem dosing for a patient with community-acquired pneumonia and an estimated creatinine clearance of 24 mL/min?
In a 65-year-old diabetic male with a weeping foul ulcer at the nape and severe facial swelling limiting eye opening, who is receiving meropenem for cellulitis and has a serum creatinine of 1.8 mg/dL, should amikacin be replaced with levofloxacin and what levofloxacin dose is appropriate for his renal function?
What is the appropriate meropenem dosing regimen for an adult with sepsis, including adjustments for severity and renal function?
What is the appropriate meropenem dose for a 76-year-old male, weight 95 kg, height 175‑180 cm, serum creatinine 134 µmol/L, post‑spine fracture surgery, febrile with urine Escherichia coli and blood gram‑positive cocci, currently on piperacillin‑tazobactam (Tazocin) empirically?
What is the appropriate treatment for acute decompensation of chronic renal insufficiency?
What is the brush sign on brain MRI, and what are its diagnostic and management implications in acute ischemic stroke?
What is the maximum dose of diazepam for sedation during MRI in an adult patient?
What is the recommended titration regimen for escitalopram in adults, including elderly patients?
At what age can Body Mass Index (BMI) be calculated?
In a patient with a known colon abscess whose white blood cell count and neutrophil count have risen after a 10‑day course of oral amoxicillin‑clavulanate (Augmentin), and whose abdominal ultrasound is otherwise unremarkable aside from unchanged gallstones, what are the next management steps?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.